Press Releases

Monika Wörwag
Change in management
After almost twenty years at the head of Woerwag Pharma GmbH & Co. KG, Monika Woerwag will step down from the management board effective on January 1, 2021. However, she will remain with the company in a management position.
research
Invitation for Submissions for the Fritz-Wörwag Research Prize 2021
In order to support research and science in the field of biofactors Wörwag Pharma announces the 10th Fritz-Wörwag Research Prize.
Monika Wörwag
Topping-out ceremony with a difference: New company building of Wörwag Pharma
Rather than holding a topping-out ceremony, in view of the corona restrictions the management of Wörwag Pharma has decided to show its employees in Böblingen the shell of the building in group tours.
Positive development worldwide: Wörwag Pharma increases its sales in 2019
With an increase in sales of 11 percent as compared to the previous year to 234.1 million euros, Wörwag Pharma, the family-owned company from Böblingen, has also brought 2019 to a successful end.
Jochen Schlindwein
Jochen Schlindwein becomes new Managing Director
Following the departure of Dr. Marcus Wörwag from the management of Wörwag Pharma GmbH & Co. KG, Mr. Jochen Schlindwein will assume management as Managing Director and CEO, starting on December 1, 2019. He will manage the business operations of the Wörwag group together with Mr. Gerhard Mayer, Managing Director and CFO.
Monika Wörwag
Positive development in Eastern Europe: Wörwag Pharma with rise of sales in first half of 2019
With an increase in sales of 8.7 percent, i. e. 118.2 million Euro, compared to the previous year, the family-owned pharma company Wörwag Pharma has successfully finished the first half of 2019.
Dr. Marcus Wörwag
Wörwag Pharma: Change in Management Board
After 18 years of leading Wörwag Pharma GmbH & Co. KG, Dr. Marcus Wörwag will withdraw from the company’s Management Board as of January 2019. Marcus Wörwag will join the Advisory Board and in this function will further develop the strategic direction of the group. Managing Directors Monika Wörwag and Gerhard Mayer henceforth will lead the company together.
European Diabetes Congress: Experts call for more attention to be paid to the feet of diabetics
Neuropathy is a common and serious secondary disease of diabetes. However, it is often not recognised for a long time. For this reason, experts from six European countries discussed at the Congress of the EASD (European Association for the Study of Diabetes) in Berlin how the early diagnosis of neuropathies can be improved.

Press Contact

Kerstin Imbery-Will
Kerstin Imbery-WillPublic relations+49 4183 774623kerstin.imbery-will@woerwagpharma.com
Tanja Thoma-Ly
Tanja Thoma-LyCompany Communications+49 7031 6204 – 338tanja.thoma-ly@woerwagpharma.com